A detailed history of Whittier Trust CO transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Whittier Trust CO holds 765 shares of REGN stock, worth $536,915. This represents 0.01% of its overall portfolio holdings.

Number of Shares
765
Previous 765 -0.0%
Holding current value
$536,915
Previous $804,000 -0.0%
% of portfolio
0.01%
Previous 0.01%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 26, 2024

SELL
$883.2 - $1071.19 $7,948 - $9,640
-9 Reduced 1.16%
765 $804,000
Q4 2023

Jan 11, 2024

BUY
$775.18 - $881.7 $376,737 - $428,506
486 Added 168.75%
774 $679,000
Q3 2023

Oct 27, 2023

BUY
$692.45 - $844.37 $24,235 - $29,552
35 Added 13.83%
288 $237,000
Q2 2023

Jul 24, 2023

SELL
$700.03 - $830.35 $1,400 - $1,660
-2 Reduced 0.78%
253 $181,000
Q1 2023

Apr 21, 2023

BUY
$680.49 - $826.97 $59,883 - $72,773
88 Added 52.69%
255 $209,000
Q3 2022

Oct 21, 2022

SELL
$573.97 - $724.32 $14,923 - $18,832
-26 Reduced 13.47%
167 $115,000
Q2 2022

Jul 28, 2022

BUY
$548.35 - $738.84 $14,257 - $19,209
26 Added 15.57%
193 $114,000
Q1 2022

Apr 29, 2022

SELL
$595.12 - $698.43 $7,141 - $8,381
-12 Reduced 6.7%
167 $117,000
Q4 2021

Jan 19, 2022

BUY
$543.48 - $670.97 $76,630 - $94,606
141 Added 371.05%
179 $113,000
Q2 2021

Jul 29, 2021

SELL
$472.8 - $558.54 $8,037 - $9,495
-17 Reduced 30.91%
38 $21,000
Q4 2020

Jan 29, 2021

SELL
$478.3 - $607.98 $6,696 - $8,511
-14 Reduced 20.29%
55 $27,000
Q3 2020

Oct 30, 2020

SELL
$544.75 - $658.21 $8,171 - $9,873
-15 Reduced 17.86%
69 $39,000
Q2 2020

Jul 10, 2020

BUY
$493.32 - $643.92 $13,812 - $18,029
28 Added 50.0%
84 $53,000
Q1 2020

Apr 27, 2020

SELL
$336.18 - $494.43 $8,068 - $11,866
-24 Reduced 30.0%
56 $27,000
Q4 2019

Jan 31, 2020

SELL
$274.13 - $376.51 $37,555 - $51,581
-137 Reduced 63.13%
80 $30,000
Q3 2019

Oct 18, 2019

BUY
$273.46 - $318.39 $53,051 - $61,767
194 Added 843.48%
217 $60,000
Q1 2019

Apr 29, 2019

SELL
$372.08 - $439.57 $16,743 - $19,780
-45 Reduced 66.18%
23 $9,000
Q4 2018

Feb 07, 2019

BUY
$335.82 - $403.04 $15,111 - $18,136
45 Added 195.65%
68 $25,000
Q2 2018

Jul 27, 2018

SELL
$284.6 - $344.99 $853 - $1,034
-3 Reduced 11.54%
23 $8,000
Q2 2018

Jul 20, 2018

SELL
$284.6 - $344.99 $9,107 - $11,039
-32 Reduced 55.17%
26 $7,000
Q4 2017

Feb 07, 2018

SELL
$358.63 - $469.95 $8,607 - $11,278
-24 Reduced 29.27%
58 $22,000
Q3 2017

Oct 23, 2017

BUY
$431.38 - $504.0 $35,373 - $41,328
82
82 $37,000

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $75.2B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Whittier Trust CO Portfolio

Follow Whittier Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Whittier Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Whittier Trust CO with notifications on news.